A meta-analysis of the accuracy of Xpert MTB/RIF in diagnosing intestinal tuberculosis

Lab Med. 2024 Mar 7;55(2):238-244. doi: 10.1093/labmed/lmad072.

Abstract

Objective: A detection method with high efficiency and accuracy is urgently needed in clinical work. The purpose of our study was to determine the diagnostic accuracy of the Xpert MTB/RIF assay for intestinal tuberculosis (ITB).

Methods: We searched PubMed and 4 other databases from their establishment to July 19, 2022, for published essays of diagnostic performance in which Xpert MTB/RIF was used to test patients with clinically suspected ITB. An assessment of the quality of the selected literature was conducted using QUADAS-2. We built forest plots by MetaDiSc software.

Results: The pooled Xpert MTB/RIF sensitivity was 48%, and the specificity was 99%. Moreover, the positive likelihood ratio for ITB diagnosis was 21.61. The negative likelihood ratio was 0.54. There were substantial variations between the study estimates of sensitivity (I2 = 87.6%) and specificity (I2 = 82.4%).

Conclusion: Intestinal TB is detected with limited diagnostic sensitivity by Xpert MTB/RIF but with high specificity. An Xpert-positive result may facilitate the rapid identification of ITB cases. Nevertheless, a negative result has less certainty in excluding the disease.

Keywords: Mycobacterium tuberculosis; Xpert MTB/RIF; diagnostic; intestinal tuberculosis; meta-analysis; tuberculosis.

Publication types

  • Meta-Analysis

MeSH terms

  • Antibiotics, Antitubercular* / pharmacology
  • Drug Resistance, Bacterial
  • Humans
  • Mycobacterium tuberculosis* / genetics
  • Rifampin / pharmacology
  • Sensitivity and Specificity
  • Tuberculosis, Pulmonary* / diagnosis

Substances

  • Rifampin
  • Antibiotics, Antitubercular